Close
Back to AVDL Stock Lookup

(AVDL) – Hot FDA News

Nov 18, 2022 02:45 PM Avadel Pharma (AVDL) Announces Favorable Ruling on Motion to Delist REMS Patent from FDA’s Orange Book
Apr 27, 2020 07:04 AM Avadel Pharma (AVDL) Phase 3 REST-ON Trial of Once-Nightly FT218 for Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy Met Endpoints

Back to AVDL Stock Lookup